The effect of chronic neuroleptic administration on cerebral dopamine receptor function (Q40090027)

17 September 2017

1 reference

title

The effect of chronic neuroleptic administration on cerebral dopamine receptor function (English)

1 reference

17 September 2017

3

Marsden CD

1 reference

17 September 2017

M. N. Rupniak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6133203

11 August 2023

P. Jenner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6133203

11 August 2023

C. D. Marsden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6133203

11 August 2023

language of work or name

English

0 references

publication date

1 May 1983

1 reference

17 September 2017

16 May 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6133203

full work available at URL

11 August 2023

https://api.elsevier.com/content/article/PII:0024320583907592?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

https://api.elsevier.com/content/article/PII:0024320583907592?httpAccept=text/plain

11 August 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

11 August 2023

1 reference

17 September 2017

32

1 reference

17 September 2017

2289-2311

1 reference

17 September 2017

20

1 reference

Stereotyped activities produced by amphetamine in several animal species and man

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Antipsychotic drug doses and neuroleptic/dopamine receptors

11 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

11 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

11 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

11 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Tolerance of haloperidol catalepsy

11 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Pharmacology of neuroleptics upon repeated administration

11 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

11 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs

11 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Biochemical mechanism of tolerance to neuroleptic drugs; Regional differences in rat brain

11 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

11 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Increased effect of apomorphine on homovanillic acid in rats terminated from chronic haloperidol

11 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

11 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

11 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats

11 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa

11 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Changes in dopamine-mediated behaviour during one year's neuroleptic administration

11 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

11 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

11 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Change in the characteristics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: Effects of buffer washing of membranes

11 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

11 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei

11 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Neuroleptic treatment for a substantial proportion of adult life: behavioural sequelae of 9 months haloperidol administration

11 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration

11 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine

11 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum.

11 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment

11 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Multiple receptors for dopamine

11 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone

11 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

11 August 2023

Pharmacological Reviews

39

32

230

Seeman

1980

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration

11 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain

11 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment

11 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

11 August 2023

Molecular Pharmacology

43

16

687

Peroutka

1979

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum.

11 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Increased dopamine-receptor sensitivity in schizophrenia

11 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

α-Flupenthixol-induced hyperactivity by chronic dosing in rats

11 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Movement disorders induced in monkeys by chronic haloperidol treatment

11 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia

11 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Long-term chlorpromazine in rhesus monkeys: production of dyskinesias and changes in social behavior

11 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Acute dystonia as an idiosyncratic response to neuroleptics in baboons

11 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.

11 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Dopamine, acetylcholine, and GABA effects in acute dystonia in primates

11 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Neuroleptic-induced acute dyskinesias in rhesus monkeys

11 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Drug holiday and management of Parkinson disease

11 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.

11 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Dopamine and schizophrenia

11 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Clozapine: reduction of the initial dopamine turnover increase by repeated treatment

11 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine

11 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol

11 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Increased mesolimbic dopamine binding following chronic haloperidol treatment

11 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system

11 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration

11 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas

11 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Dopamine Nerve Terminals in the Rat Limbic Cortex: Aspects of the Dopamine Hypothesis of Schizophrenia

11 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Antipsychotic Drug Action in Schizophrenic Patients: Effect on Cortical Dopamine Metabolism After Long-Term Treatment

11 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

The effect of long-term concurrent administration of chlorpromazine and lithium on the striatal and frontal cortical dopamine metabolism in rats

11 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment

11 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens

11 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

The role of catecholamines in the release of anterior pituitary prolactin in vitro.

11 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated

11 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Normal prolactin responses in tardive dyskinesia

11 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with effects on rat prolactin secretion

11 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0024-3205(83)90759-2

11 August 2023

Identifiers

1 reference

17 September 2017

1 reference